Registry of Thrombosis & NEoplasia of "Sociedad Española de Oncología Médica"
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorFundación Sociedad Española de Oncologia Médica
About this trial
Epidemiological, observational, non-interventional, multicentric study on patients diagnosed with cancer who develop a venous or arterial thromboembolic episode, symptomatic or incidental, within a month prior to cancer diagnosis or at anytime after such diagnosis
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Over 18 years of age with a histologically confirmed diagnosis of malignant tumor.
Venous or arterial thromboembolism episode, symptomatic or incidental, in the month prior or any time after the cancer diagnosis and in the three previous months to enrollment, confirmed with an imaging technique: Doppler echocardiography, computed tomography (CT) angiography, etc.
Signing of informed consent.
Disqualifiers
Clinical diagnosis of thromboembolic event without radiological confirmation.
Presenting a single episode of superficial thrombophlebitis without association with another thromboembolic event.
Each patient will be recorded just once, and therefore a second thromboembolic event will be considered a rethrombosis and will be recorded as such. Patients with a rethrombosis and a previous thromboembolic event before the start of the study in each center will not be able to be included.
Trial population
Cancer patients
Trial design
Design model
Other
Time perspective
Prospective
Treatments tested in this trial
Not listed
Trial groups
No trial groups listed
Trial outcomes
Primary outcomes
1
Location of origin of the thromboembolytic event
Distribution in the number of patients according to the anatomical location affected by the thromboembolytic event.
Time frame
Baseline2
Vessel of origin of the thromboembolytic event
Distribution in the number of patients according to the type of vessel affected by the thromboembolytic event.
Time frame
Baseline3
Thromboembolytic event diagnosis type
Proportion of patients with incidental versus symptomatic thormboembolic events
Time frame
Baseline4
Primary tumor at the time of the thromboembolic event
Distribution of patients according to the organ affected by the primary tumor.
Time frame
BaselineSponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov